Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus

British Journal of Dermatology

Volumn 156, Issue 4, 2007, Pages 635-641

  Mentink, L F ^a   De Jong, M C J M ^a   Kloosterhuis, G J ^a   Zuiderveen, J ^a   Jonkman, M F ^a   Pas, H H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Autoimmunity; Desmoglein; IgA; Mucosa; Pemphigus; Skin

Indexed keywords

AUTOANTIBODY; DESMOGLEIN 1; DESMOGLEIN 3; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; MAJOR CLINICAL STUDY; PARANEOPLASTIC PEMPHIGUS; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; STAINING;

AUTOANTIBODIES; AUTOANTIGENS; DESMOGLEIN 1; DESMOGLEIN 3; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; PARANEOPLASTIC SYNDROMES; PEMPHIGUS;

EID: 33947375694     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07717.x     Document Type: Article

References (27)

1. Amagai M. Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sci 1999; 20:92-102.
2. Amagai M. Desmoglein as a target in autoimmunity and infection. J Am Acad Dermatol 2003; 48:244-52.
3. Anhalt GJ, Kim SC, Stanley JR et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323:1729-35.
4. Amagai M, Tsunoda K, Zillikens D et al. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999; 40:167-70.
5. Harman KE, Gratian MJ, Shirlaw PJ et al. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris. Br J Dermatol 2002; 146:684-7.
6. Miyagawa S, Amagai M, Iida T et al. Late development of anti-desmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression. Br J Dermatol 1999; 141:1084-7.
7. Ding X, Aoki V, Mascaro JM Jr et al. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol 1997; 109:592-6.
8. Harman KE, Seed PT, Gratian MJ et al. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001; 144:775-80.
9. Harman KE, Gratian MJ, Bhogal BS et al. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype. Br J Dermatol 2000; 143:343-8.
10. Toth GG, Pas HH, Jonkman MF. Transition of pemphigus vulgaris into pemphigus foliaceus confirmed by antidesmoglein ELISA profile. Int J Dermatol 2002; 41:525-7.
11. Jamora MJ, Jiao D, Bystryn JC. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 2003; 48:976-7.
12. Nguyen VT, Lee TX, Ndoye A et al. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol 1998; 134:971-80.
13. Christophoridis S, Budinger L, Borradori L et al. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis. Br J Dermatol 2000; 143:349-55.
14. Murakami H, Nishioka S, Setterfield J et al. Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid. J Dermatol Sci 1998; 17:39-44.
15. Setterfield J, Shirlaw PJ, Kerr-Muir M et al. Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br J Dermatol 1998; 138:602-10.
16. Hashimoto T, Kiyokawa C, Mori O et al. Human desmocollin 1 (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol 1997; 109:127-31.
17. Spaeth S, Riechers R, Borradori L et al. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris. Br J Dermatol 2001; 144:1183-8.
18. Futei Y, Amagai M, Ishii K et al. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. J Dermatol Sci 2001; 26:55-61.
19. Preisz K, Horvath A, Sardy M et al. Exacerbation of paraneoplastic pemphigus by cyclophosphamide treatment: detection of novel autoantigens and bronchial autoantibodies. Br J Dermatol 2004; 150:1018-24.
20. Ohyama M, Amagai M, Hashimoto T et al. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus. J Am Acad Dermatol 2001; 44:593-8.
21. Nikolskaia OV, Nousari CH, Anhalt GJ. Paraneoplastic pemphigus in association with Castleman's disease. Br J Dermatol 2003; 149:1143-51.
22. Amagai M, Nishikawa T, Nousari HC et al. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 1998; 102:775-82.
23. Ishii N, Ishida-Yamamoto A, Hashimoto T. Immunolocalization of target autoantigens in IgA pemphigus. Clin Exp Dermatol 2004; 29:62-6.
24. Hashimoto T. Immunopathology of IgA pemphigus. Clin Dermatol 2001; 19:683-9.
25. Oiso N, Yamashita C, Yoshioka K et al. IgG/IgA pemphigus with IgG and IgA antidesmoglein 1 antibodies detected by enzyme-linked immunosorbent assay. Br J Dermatol 2002; 147:1012-17.
26. Kozlowska A, Hashimoto T, Jarzabek-Chorzelska M et al. Pemphigus herpetiformis with IgA and IgG antibodies to desmoglein 1 and IgG antibodies to desmocollin 3. J Am Acad Dermatol 2003; 48:117-22.
27. Hashimoto T, Komai A, Futei Y et al. Detection of IgA autoantibodies to desmogleins by an enzyme-linked immunosorbent assay: the presence of new minor subtypes of IgA pemphigus. Arch Dermatol 2001; 137:735-8.